Critical Aspects of Developing and Launching an Oncology Drug and Companion Diagnostic Hosted by Xtalks

Share Article

Xtalks presents an exciting live webinar on Friday April 19, 2013 at 11:00am EDT on optimizing co-development of novel therapeutics and companion diagnostics in oncology. The event will focus on critical aspects that can make or break development, regulatory submission, launch, and adoption of both the drug and the companion diagnostic.

News Image

Misalignment of oncology therapeutics with their companion diagnostic can have a significant negative impact on pharma’s planning, budget and operations, and market uptake of both products once regulatory approval is achieved. More broadly, misalignment of risk between pharma and IVD players may result in strained development programs and business relationships.

In the last several years, the industry has seen two anti-cancer drugs (Xalkori and Zelboraf) demonstrate simultaneous therapeutic and diagnostic approval, illustrating successful scenarios for companion diagnostic and targeted oncologic parallel development. However, this is often not the reality for many oncology development programs, as exemplified by Tarceva and Iressa. In many cases, programs lack the benefits of co-development and the opportunity to influence the type and performance of the diagnostic test.

This webinar will examine key steps for Pharma in oncology development including:

  •     Key strategic priorities in the planning of oncology drug and diagnostic test development and launch
  •     Considerations for platform/assay selection and strategic partnering early in the clinical development program
  •     Generating the right evidence to gain regulatory approval and optimize pricing and reimbursement of both the drug and the diagnostic in global markets

For more information about this event or to register, visit:

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global Life Sciences community. Every year thousands of industry practitioners turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit

Karen Lim (416) 977-6555 ext 227

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Client Services
(416) 977-6555 227
Email >
Visit website